Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

ABSTRACT:

Importance

Human immunodeficiency virus (HIV) management in correctional settings is logistically feasible, but HIV-related outcomes before release have not been recently systematically examined.

Objective

To evaluate HIV treatment outcomes throughout incarceration, including jail and prison.

Design, setting, and participants

Retrospective cohort study of longitudinally linked demographic, pharmacy, and laboratory data on 882 prisoners within the Connecticut Department of Correction (2005-2012) with confirmed HIV infection, who were continually incarcerated 90 days or more, had at least 2 HIV-1 RNA and CD4 lymphocyte measurements, and were prescribed antiretroviral therapy.

Main outcomes and measures

Three electronic databases (correctional, laboratory, and pha

SUBMITTER: Meyer JP 

PROVIDER: S-EPMC4074594 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature